Welcome to deNovo Medica Accredited CPD Modules – Earn 3 CPD points

NewWhat’s new in inflammatory bowel disease – a focus on biologic sequencing
Latest Module

What’s new in inflammatory bowel disease – a focus on biologic sequencing

Highlights from the 2023 European Crohn’s and Colitis Organisation (ECCO) Congress, covering inflammatory bowel disease, biologic therapies, new agents and strategies

Earn up to 3 CPD points now »

Breaking through the complexity of managing type 2 diabetes

Breaking through the complexity of managing type 2 diabetes

Three case studies are briefly presented, providing clinical guidance on the intensification of insulin therapy

Earn up to 3 CPD points »

Strategies to improve motor control in Parkinson’s disease

Strategies to improve motor control in Parkinson’s disease

Existing clinical strategies to manage motor features in the different stages of the clinical course of Parkinson’s disease

Earn up to 3 CPD points »

START Module 5: Making patients partners in their care

Strategies to improve motor control in Parkinson’s disease

The plight of the asthma patient in South Africa

START Case Study 1: Effectively starting patient insulin therapy

Breaking through the complexity of diabetes management and improving cardiovascular health through lipid management

Women and Cardiovascular Disease – a focus on heart failure trials

COPD management – Ensuring patients get the right treatment

Type 2 diabetes and ASCVD

Inflammatory arthritis – Treatment approaches in the era of biologics

Weight loss case studies: Metabolic syndrome and regular travel, adolescence, and PCOS

Calcium and Vitamin D – An approach to bone care while considering safety concerns

Cough treatments in the spotlight

Managing LDL-cholesterol after an acute coronary event

Big bully – An epidemic of unkindness

Anticoagulation in the patient with atrial fibrillation who suffers a stroke

Managing patient information – What are the responsibilities of healthcare providers?

Immune-related inflammatory disorders – improving therapy, improving quality of life

Chronic Asthma in Adults

Medical records – issues of negligence in daily practice

Optimising patient care in atrial fibrillation

American College of Cardiology and World Heart Federation Update 2023

Breaking through the complexity of managing type 2 diabetes

The truth about obesity

Time in range – What is it, and does it matter?

Managing childhood asthma – best practice options

START Module 2: Insulins: An introduction

Allergic rhinitis – early detection and diagnosis

Common cold, sinusitis or chronic rhinitis?

Acute Asthma Management

START Module 4: Intensifying insulin

Bones, kidneys and hearts – three moving targets

Issues and answers in Asthma Management: Practical approach to inhalers

Changing the shape of obesity

Comprehensive care – long COVID and diseases of ageing

Current asthma management – Best practice in 2023

Latest SA Guidelines on Paediatric Asthma

Ethical dilemmas in managing sports injuries

Baricitinib therapy in Rheumatoid arthritis

Breaking through the complexity of managing type 2 diabetes – Case study 2

Fracture risk assessment in osteoporosis

Breaking through the complexity of managing type 2 diabetes – Case Study 1

START – The transition to insulin

The POPI Act is here! What now? A quick guide to POPIA-fying your practice

European Society of Cardiology (ESC) Congress 2023

Insulin – A call to action: Case studies in type 2 diabetes

Lipid-lowering therapies – strengths, weaknesses, opportunities, threats

Adolescents with obesity: Weight stigma and other barriers to treatment

Practical considerations in cancer-associated thrombosis

Case studies in rheumatoid arthritis and psoriatic arthritis

Multiple sclerosis in primary care – diagnosis and early treatment

Rewinding cardiovascular risks

Chronic illness and Ramadan fasting – Optimal management for patients intending to fast

Recognising colchicine role in cardiovascular disease prevention

START Module 3: Insulin initiation in type 2 diabetes

Is lower better? LDL Cholesterol in perspective

Probiotics, prebiotics and postbiotics – The gut microbiome re-imagined

A five-step guideline approach to obesity management

Treating hypercholesterolaemia – too little, too late

Pharmacotherapy for the management of obesity

Rethinking primary CVD prevention in type 2 diabetes today

Ethics and vulnerability

Practice alert – Early use of abemaciclib increases survival of breast cancer patients

At the heart of cold and influenza medication – clinical use today

Primary prevention of diseases of ageing – Use the benefits of menopausal hormone therapy

Practical Obesity Management

Obesity – helping patients to lose that extra weight

Osteoporosis as a life-time disease – How to manage expectations

Best clinical practice – Allergic rhinitis treatment

Psoriasis Case Studies: Immunologic therapies – a new era of dermatology

Challenges in the management of geriatric oncology patients

Breaking through the complexity of managing type 2 diabetes – Case study 3

START Case Study 2: The transition to insulin

The pathophysiology of dry skin and implications for topical emollients

The patient’s journey with dulaglutide – Type 2 diabetes clinical cases

Ixekizumab and newer therapies for plaque psoriasis

The essence and ethics of patient-centred care

START Case Study 3: Intensifying and switching insulins

Treating and caring for our queen of hearts women and heart disease – Local experience and issues of care

The revolution in type 2 diabetes – Obesity and new therapies

START Module 1: Initiating insulin

Weight loss case studies: Poor lifestyle choices and the patient with comorbidities

New technologies to avoid cervical cancer misdiagnosis

Case Study: Hypertension in the black African patient – best practice approach to managing blood pressure

Issues and Answers: Practical guidance on managing adolescent obesity

The heart and diabetes – Is pre-diabetes a treatable entity?

Treating dyslipidaemia and hypertension – A practical clinical approach

Women and cardiovascular disease – how different is the clinical course and outcome

What’s new in inflammatory bowel disease – a focus on biologic sequencing